The use of AI will transform patient outcomes, report finds

By Catherine Sturman
A recent report by Juniper Research has stated that not only will AI transform and shape the role in which digitisation will play within healthcare sect...

A recent report by Juniper Research has stated that not only will AI transform and shape the role in which digitisation will play within healthcare sector, the total spending on CAD (computer aided diagnosis) systems will reach $800.7 million by 2022.

It also adds that “by 2022, 28.4 million chronic disease scans will also be fed into first-line CAD systems annually.”

Large volumes of data routinely inputted into healthcare systems and Electronic Health Records (EHRs) will ultimately be harnessed in a bid to improve and provide exceptional patient centered care, as well as create an element of convenience with patients through implementing online booking systems, and the ability to speak to a medical professional, anytime, anywhere.

Related stories

The implementation of CAD systems will also provide the ability to look at certain trends within a number of chronic conditions through the use of diagnostics, and consequently lower costs across the board and enable acute healthcare settings to provide higher quality treatment options.

Nonetheless, with recent worldwide cyber-security attacks, such as the WannaCry attack involving the National Health Service in the United Kingdom, the need for IT infrastructures and cloud systems remains paramount within any risk analysis taken.

Current healthcare regulations under the European Union are consequently being revised, as well as the General Data Protection Regulation, which will become more specific and provide a more robust set of processes which businesses will need to follow.

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma